Litcius/Paper detail

Rifabutin for infusion (BV100) for the treatment of severe carbapenem-resistant Acinetobacter baumannii infections

Vincent Trebosc, Christian Kemmer, Sergio Lociuro, Marc Gitzinger, Glenn E. Dale

2021Drug Discovery Today19 citationsDOI

Topics & Concepts

RifabutinRifamycinAcinetobacter baumanniiAntibioticsMicrobiologyRifampicinCephalosporinCarbapenemMedicinePathogenMycobacteriumBiologyBacteriaTuberculosisClarithromycinPathologyPseudomonas aeruginosaGeneticsAntibiotic Resistance in BacteriaTuberculosis Research and EpidemiologyPneumocystis jirovecii pneumonia detection and treatment
Rifabutin for infusion (BV100) for the treatment of severe carbapenem-resistant Acinetobacter baumannii infections | Litcius